The Society of Infectious Diseases Pharmacists (SIDP) supports development and/or expansion of new advanced training opportunities for pharmacists committed to Infectious Diseases Pharmacotherapy.
PurposeThe Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the availability of funding for one Infectious Diseases Pharmacy Residency for the period of July 2024 through June 2025. The intent of this funding is to foster the development and/or expansion of new advanced training opportunities for pharmacists committed to the practice area of infectious diseases pharmacotherapy.
Applications will be considered from programs developing a new infectious diseases specialty training program in 2024 or established programs expanding the number of available infectious diseases resident positions.
SIDP will provide funding to support resident salary for one year plus fringe benefits, participation in the SIDP Antimicrobial Stewardship Certificate Program, and attendance at the SIDP live Business Meeting at IDWeek™. The total grant is not to exceed $75,000 and up to $2,000 may be used for travel expenses to the SIDP Business Meeting. The program will be responsible for expenses exceeding the grant amount.
Proposals must be submitted no later than 5 PM E.D.T. on August 14, 2023. Applications submitted after this deadline will not be considered.
The Board of Directors will make decisions on the applications no later than September 15, 2023.
Applications should be entered online using the resident award application form (above). The RPD cover letter, two (2) letters of support, and curriculum vitaes (up to 4) should be converted to a single PDF file and uploaded. Other information will be directly inserted on the web form.
Applicants are encouraged to refer to the ASHP Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Infectious Diseases. These guidelines were prepared by ASHP, in collaboration with ACCP and SIDP, and endorsed by the SIDP Board of Directors. SIDP supports the utility of the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pharmacy Residencies in Infectious Diseases for any residency funded by SIDP. SIDP also requests grant awardees to seek ASHP accreditation for applicants applying for a new program.
Required Elements for Application
Application Criteria and Eligibility
Residency Program Director/Primary Preceptor:
Terms and Conditions
Members who are awarded funding must send a copy of the letter of acceptance from the resident, the resident's CV, and proof of PGY1 residency training to Shelley Warnock (email@example.com) no later than May 1, 2024 or the award will be rescinded. A midpoint and final report of the resident’s activities (e.g., rotations including stewardship activities, key presentations, longitudinal research) will be also required.
Questions regarding submission may be submitted to SIDP Board Member-at-Large Alan Gross (firstname.lastname@example.org).
PurposeThe intent of this funding is to foster the development and/or expansion of new advanced training opportunities for pharmacists committed to research in infectious diseases pharmacotherapy. Applications will only be considered from fellowship programs developing a new infectious diseases specialty research training program or established programs expanding the number of available infectious diseases fellowship positions.
For fellows, applicants are encouraged to refer to the American College of Clinical Pharmacy Guidelines for Research Fellowship Training Programs.
SIDP members who have received an SIDP Residency Award as Residency Director in the past, institutions who have received an SIDP Residency or Fellowship Award in the past three years, and current members of the SIDP Board of Directors are ineligible for these awards.
2022 Award Winner